Lu Rahman - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Lu Rahman's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Lu Rahman

Lu Rahman

Verified

Publishing Director, Drug Discovery World

Greater Manchester

Final Covers

fashion, science, lifestyle, beauty Covid-19, sleep, celebrities, public healthCovers: Medical, wellness, family, stress health, aging, nutrition, fitness mental health, biology, resilience, disease

Journalist Type

-

Seniority Positions

Industries

-

Medium Formats

Content

Total articles 547

  • Blocking key enzyme boosts anti-cancer T-cell responses and resistance to immunosuppression

    By Lu Rahman Verified| Drug Discovery World Verified Posted in Cancer Research, Editor's Choice, News | Tagged Cancer Research, Immunotherapy, Oncology, T-Cells A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strategy to overcome tumour-induced immunosuppression. For the first time, the research team identified a critical immunosuppressive pathway and a promising approach to intervene, protecting the ability of T-cells to attack cancer cells.

    By Lu Rahman Verified · Drug Discovery World

    Aug. 31, 2022

  • Algorithm uncovers the secrets of cell factories: useful for studying disease

    By Lu Rahman Verified| Drug Discovery World Verified Drug molecules and biofuels can be made to order by living cell factories, where biological enzymes do the job. Now researchers at Chalmers University of Technology have developed a computer model that can predict how fast enzymes work, making it possible to find the most efficient living factories, as well as to study difficult diseases. Enzymes are proteins found in all living cells.

    By Lu Rahman Verified · Drug Discovery World

    Aug. 31, 2022

  • Blocking key enzyme boosts anti-cancer T-cell responses and resistance to immunosuppression

    By Lu Rahman Verified| Drug Discovery World Verified Posted in Cancer Research, Editor's Choice, News | Tagged Cancer Research, Immunotherapy, Oncology, T-Cells A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strategy to overcome tumour-induced immunosuppression. For the first time, the research team identified a critical immunosuppressive pathway and a promising approach to intervene, protecting the ability of T-cells to attack cancer cells.

    By Lu Rahman Verified · Drug Discovery World

    Aug. 31, 2022

As seen in

Company Info

Drug Discovery World

London, England, United Kingdom

+1 212-321-4080